(Q85063666)
Statements
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) (English)
Paul M Ridker
Peter Libby
Andrew Zalewski
14 September 2011